Treatment response and tolerability of intralesional quadrivalent versus bivalent human papillomavirus vaccine for recalcitrant warts: A randomized controlled trial.

Authors :: Nofal A
Nofal H
Alwirshiffani E
ElGhareeb MI
Source :: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 Nov; Vol. 89 (5), pp. 1051-1052. Date of Electronic Publication: 2023 Jul 06.
Publication Year :: 2023
Abstract: Competing Interests: Conflicts of interest None disclosed.

Subjects :: Humans
Female
Human Papillomavirus Viruses
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Papillomavirus Vaccines adverse effects
Warts drug therapy
Papillomavirus Infections prevention & control
Uterine Cervical Neoplasms

Full Text Access

Tools